ArticleCEN case reports2026
Delayed diagnosis of MEN1 after kidney transplantation: unrecognized pre-transplant features and implications for clinical practice.
Article in CEN case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multiple endocrine neoplasia type 1 (MEN1), characterized by multiglandular endocrine tumors such as hyperparathyroidism (HPT), is an autosomal dominant disorder caused by mutations of the MEN1 gene. In patients with chronic kidney disease (CKD), abnormalities in calcium-phosphate metabolism may obscure this diagnosis, making the recognition of MEN1 challenging. A 68-year-old man with end-stage renal disease underwent an ABO-compatible living-donor kidney transplantation (KT); however, persistent hypercalcemia prompted further evaluation, which revealed recurrent HPT with bilateral parathyroid enlargement. Pre-transplant imaging revealed an adrenal adenoma and a pancreatic tail lesion. Subsequent pituitary magnetic resonance imaging and genetic testing confirmed the diagnosis of MEN1. A retrospective review of the patient's medical history revealed several pre-transplant findings suggestive of MEN1 that had not been recognized. This case highlights that MEN1 may remain unrecognized in KT candidates owing to the occurrence of metabolic abnormalities also associated with CKD. The early recognition of MEN1 in KT candidates with recurrent or multiglandular hyperparathyroidism may improve pre-transplant risk assessment and enable appropriate long-term oncological surveillance.
Indexed as
Identifiers
42909780What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.